This post-translational regulation of CDK4/6 is likely responsible for the cell cycle arrest observed in G1 phase, further supporting the therapeutic potential of LA-CB1 as a cancer treatment targeting CDK4/6-mediated proliferation. The gene discussed is CDK4; the disease is cancer.